Ken Griffin Opko Health, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Opko Health, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 584,400 shares of OPK stock, worth $864,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
584,400
Previous 495,600
17.92%
Holding current value
$864,912
Previous $594,000
22.9%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding OPK
# of Institutions
250Shares Held
184MCall Options Held
4.23MPut Options Held
8.83M-
Rubric Capital Management LP New York, NY44.4MShares$65.7 Million1.64% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$43.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.2MShares$41.8 Million0.0% of portfolio
-
State Street Corp Boston, MA9.55MShares$14.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.82MShares$13.1 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $1.14B
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...